
Gordon Buchanan MD, PhD, receives the Epilepsy Foundation's "Targeted Research Initiative for Morbidity and Mortality" grant for $50,000 in 2016.
Research by Epilepsy Foundation grantee Dr. Gordon Buchanan and colleagues sought to study role of neurotransmitters, such as serotonin (5-HT) and norepinephrine (NE), in sudden unexpected death in epilepsy (SUDEP). Their work was published in an Epilepsia article titled, “Effect of monoamine reuptake inhibition and α1 blockade on respiratory arrest and death following electroshock-induced seizures in mice.”